Novartis Working to Reduce Risk for Patients with Lipid Disorders – Pharmaceutical Processing | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/07/novartis-working-to-reduce-risk-for-patients-with-lipid-disorders-pharmaceutical-processing/

Pharmaceutical ProcessingNovartis Working to Reduce Risk for Patients with Lipid DisordersPharmaceutical ProcessingNovartis invests in next generation therapies to reduce cardiovascular risk in patients with underlying lipid disorders. Novartis announced a collaboration and option agreement with Ionis Pharmaceuticals, Inc. and its affiliate Akcea Therapeutics, Inc …and more » http://internationalnewslive.com/novartis-working-to-reduce-risk-for-patients-with-lipid-disorders-pharmaceutical-processing/